Publication:
Diagnosis, pharmacotherapy and cognitive behavioral therapy of trichotillomania

dc.contributor.authorsKonkan, Ramazan; Senormanci, Omer; Sungur, Mehmet Z.
dc.date.accessioned2022-03-10T15:25:07Z
dc.date.accessioned2026-01-11T10:42:04Z
dc.date.available2022-03-10T15:25:07Z
dc.date.issued2011
dc.description.abstractDiagnosis, pharmacotherapy and cognitive behavioral therapy of trichotillomania Trichotillomania is defined as significant hair loss due to individuals' repetitive self-pulling of hair. It is a chronic disorder that leads to significant distress and functional impairment and is often difficult to treat. Although it has been recognized for a long time, it has attracted less attention from scholars compared to other psychiatric disorders. Despite the fact that it is classified as an impulse control disorder, there is still a debate on how it should be classified. Research regarding etiology and treatment of trichotillomania has increased over last twenty years. It has been mentioned that its etiology is based on evolutional, genetic, neurophysiological and neurocognitive factors. Although robust evidence is not available, drugs such as clomipramine and selective serotonin reuptake inhibitors (SSRIs) or cognitive behavioral therapy are promising treatments. Habit Reversal Training (HRT), as a cognitive behavioural technique, has the highest rate of success in treating trichotillomania. However, not revealing the the habit of pulling hair or not coming forward to seek help due to embarrassment is an obstacle to running large scale controlled experiments. A series of multi-centered, coordinated large scale studies are needed to explore the etiology of the disorder, reach an agreement on its classification and defining the best approach and algorithms for the treatment. In this review it is aimed to summarise the latest research and progress in etiology classification and treatment of trichotillomania.
dc.identifier.doi10.5455/bcp.20110904062905
dc.identifier.issn1017-7833
dc.identifier.urihttps://hdl.handle.net/11424/220115
dc.identifier.wosWOS:000296684400017
dc.language.isotur
dc.publisherKURE ILETISIM GRUBU A S
dc.relation.ispartofKLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTrichotillomania
dc.subjectHabit Reversal Training (HRT)
dc.subjectcognitive behavioral therapies
dc.subjectpharmacotherapy
dc.subjectOBSESSIVE-COMPULSIVE DISORDER
dc.subjectHABIT REVERSAL
dc.subjectDOUBLE-BLIND
dc.subjectDESCRIPTIVE PSYCHOPATHOLOGY
dc.subjectBASAL GANGLIA
dc.subjectHAIR
dc.subjectCOMORBIDITY
dc.subjectFLUOXETINE
dc.subjectCHILDREN
dc.subjectSCALE
dc.titleDiagnosis, pharmacotherapy and cognitive behavioral therapy of trichotillomania
dc.typereview
dspace.entity.typePublication
oaire.citation.endPage274
oaire.citation.issue3
oaire.citation.startPage265
oaire.citation.titleKLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
oaire.citation.volume21

Files